Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).

× No keyword cloud information.

14 in total

Review 1. Progress and challenges in viral vector manufacturing.

Authors: Johannes C M van der Loo; J Fraser Wright
Journal: Hum Mol Genet Date: 2015-10-30 Impact factor: 6.150

2. Cell encapsulation utilizing PEG-fibrinogen hydrogel supports viability and enhances productivity under stress conditions.

Authors: Noam Cohen; Einat Toister; Yonatan Lati; Meni Girshengorn; Lilach Levin; Lea Silberstein; Dror Seliktar; Eyal Epstein
Journal: Cytotechnology Date: 2018-02-21 Impact factor: 2.058

3. Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors: Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal: Virology Date: 2014-05-24 Impact factor: 3.616

Review 4. Japanese encephalitis and vaccines: past and future prospects.

Authors: Maria Paulke-Korinek; Herwig Kollaritsch
Journal: Wien Klin Wochenschr Date: 2008 Impact factor: 1.704

5. The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.

Authors: Elisabeth Casademunt; Kristina Martinelle; Mats Jernberg; Stefan Winge; Maya Tiemeyer; Lothar Biesert; Sigurd Knaub; Olaf Walter; Carola Schröder
Journal: Eur J Haematol Date: 2012-06-15 Impact factor: 2.997

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).

Review 1. Progress and challenges in viral vector manufacturing.

2. Cell encapsulation utilizing PEG-fibrinogen hydrogel supports viability and enhances productivity under stress conditions.

3. Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Review 4. Japanese encephalitis and vaccines: past and future prospects.

5. The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.

6. In-column ATR-FTIR spectroscopy to monitor affinity chromatography purification of monoclonal antibodies.

7. Of [Hamsters] and men: a new perspective on host cell proteins.

Review 8. Matrix and backstage: cellular substrates for viral vaccines.

9. Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein.

Review 10. Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.